Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs losartan for mild to moderate primary hypertension
CTR20131822Phase 2Active
- Sponsor
- Jiarko Pharmaceutical
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in essential hypertension, sponsored by Jiarko Pharmaceutical. Started May 2014; status: active.
02
Drugs
eplerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20131822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131822.